🙃 Inverse Cramer Weekly Update – Dec 12
MONDAY JAN 6
It missed the revenues, but you know what? This is a company that is so down from where it was. I think you can buy it (Buy, Buy, Buy). There are a few welders around, and that is a good manufacturer.
-On LECO ($LECO)
I’m not that high on gambling stocks right now. There are too many of them, and we need consolidation.
-On Caesars ($CZR)
I want to own Crispr—I keep seeing their name come up in all the science papers I read. Let’s put some away, and if it goes lower, we will buy more.
-On Crispr Therapeutics ($CRSP)
TUESDAY JAN 7
They don’t have the best pipeline. I’d be careful.
-On Novo Nordisk ($MVO)
Right now, it’s in the crosshairs of the GLP-1 situation.
-On PepsiCo ($PEP)
It’s up too much. You’ve got to let it come down. It’s losing a fortune.
-On Lemonade ($LMND)
WEDNESDAY JAN 8
It’s too early to sell. I can’t recommend it and I don’t want you to sell if you have it. Let the dividend do its job.
-On Pfizer ($PFE)
I’ve had it with Quantumscape. I would be a seller, even at this level.
-On Quantumscape ($QS)
It has been a big big disappointment.
-On Powell Industries ($POWL)
THURSDAY JAN 9
No lightning round.
FRIDAY JAN 10
I really like it. It really is the solution, I think, in a lot of ways, to a Pentagon budget that may be too bloated but needs to be more effective (Buy, Buy, Buy). I like AVAV.
-On Aerovironment ($AVAV)
Modern military, modern defense, I like the story very much. You’re in good shape.
-On Kratos Defense ($KTOS)
I don’t like to buy a stock just for the yield and when it doesn’t have enough growth.
-On Verizon ($VZ)
CRAMER CLASSICS
That’s a wrap. As always, we’ll be following Cramer’s every move, so you can do the opposite.
See you tomorrow,
-IC